martes, 16 de febrero de 2021

Cost-Effectiveness of Targeted Genetic Testing for Breast and Ovarian Cancer: A Systematic Review. Koldehoff Andreas et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2021 Feb 24(2) 303-312

Main|Search|PHGKB

No hay comentarios:

Publicar un comentario